Catalyst Wire Dossier Catalyst Wire Dossier

Myrin P Forte

rifampicin/isoniazid/ethambutol/pyrazinamide fixed-dose combination · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Myrin P Forte, covering 2012-03-16 to 2012-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults [Phase 1]

See pricing